Dr. William T. Leslie

Claim this profile

Rush University Medical Center

Studies Colorectal Cancer
Studies Colon Cancer
1 reported clinical trial
5 drugs studied

Area of expertise

1Colorectal Cancer
William T. Leslie has run 1 trial for Colorectal Cancer. Some of their research focus areas include:
Stage IV
dMMR positive
MSI-H positive
2Colon Cancer
William T. Leslie has run 1 trial for Colon Cancer. Some of their research focus areas include:
Stage IV
dMMR positive
MSI-H positive

Affiliated Hospitals

Image of trial facility.
Rush University Medical Center

Clinical Trials William T. Leslie is currently running

Image of trial facility.

Chemotherapy + Bevacizumab + Atezolizumab

for Colorectal Cancer

This phase III trial studies how well combination chemotherapy, bevacizumab, and/or atezolizumab work in treating patients with deficient deoxyribonucleic acid (DNA) mismatch repair colorectal cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as fluorouracil, oxaliplatin, and leucovorin calcium, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Bevacizumab may stop or slow colorectal cancer by blocking the growth of new blood vessels necessary for tumor growth. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving combination chemotherapy, bevacizumab, and atezolizumab may work better in treating patients with colorectal cancer.
Recruiting2 awards Phase 31 criteria

More about William T. Leslie

Clinical Trial Related6 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments William T. Leslie has experience with
  • Atezolizumab
  • Bevacizumab
  • Fluorouracil
  • Leucovorin
  • Oxaliplatin
Breakdown of trials William T. Leslie has run
Colorectal Cancer
Colon Cancer

Other Doctors you might be interested in

Brian Cole, MDMidwest Orthopedics at RUSH
Alan TanRush University Medical Center
Cesar Ochoa-Lubinoff, MDRush University Medical Center

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does William T. Leslie specialize in?
William T. Leslie focuses on Colorectal Cancer and Colon Cancer. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are dMMR positive.
Is William T. Leslie currently recruiting for clinical trials?
Yes, William T. Leslie is currently recruiting for 1 clinical trial in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that William T. Leslie has studied deeply?
Yes, William T. Leslie has studied treatments such as Atezolizumab, Bevacizumab, Fluorouracil.
What is the best way to schedule an appointment with William T. Leslie?
Apply for one of the trials that William T. Leslie is conducting.
What is the office address of William T. Leslie?
The office of William T. Leslie is located at: Rush University Medical Center, Chicago, Illinois 60612 United States. This is the address for their practice at the Rush University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top